H-Ras gene takes part to the host immune response to COVID-19

• Published in: Cell Death Discovery
• Main Authors: Salvatore Sciacchitano, Andrea Sacconi, Claudia De Vitis, Giovanni Blandino, Giulia Piaggio, Valentina Salvati, Christian Napoli, Paolo Marchetti, Beatrice Salimbeni Taurelli, Flaminia Coluzzi, Monica Rocco, Andrea Vecchione, Paolo Anibaldi, Adriano Marcolongo, Gennaro Ciliberto, Rita Mancini, Carlo Capalbo
• Format: Article
• Language: English
• Published: Nature Publishing Group 2021-06-01
• Online Access: https://doi.org/10.1038/s41420-021-00541-w

Abstract Ras gene family members play a relevant role in cancer, especially when they are mutated. However, they may play additional roles in other conditions beside cancer. We performed gene expression analysis using the NanoString PanCancer IO 360 panel in the peripheral blood mononuclear cell (PBMC) of six COVID-19 patients and we found that H-Ras gene was significantly upregulated, while both K-Ras and N-Ras genes were downregulated. In particular, H-Ras gene upregulation was more evident in COVID-19 patients with a more severe disease. We compared our results with those obtained by analyzing two different and independent datasets, including a total of 53 COVID-19 patients, in which the gene expression analysis was performed using the Immunology_V2 panel. Comparative analysis of the H-Ras gene expression in these patients confirmed our preliminary results. In both of them, in fact, we were able to confirm the upregulation of the expression of the H-Ras gene. The exact role of this specific upregulation of the H-Ras gene in response to SARS-CoV-2 infection and its possible role in cancer still remains to be elucidated. In conclusion, H-Ras gene participates to the host immune response to SARS-CoV-2 virus infection, especially in patients affected by the most severe form of the COVID-19.